argenx to Present at Upcoming Investor Conferences
November 01 2023 - 2:00AM
November 1,
2023Amsterdam, the Netherlands – argenx
(Euronext & Nasdaq: ARGX), a global immunology company
committed to improving the lives of people suffering from severe
autoimmune diseases, today announced that members of management
will participate in several upcoming investor conferences in
November:
-
Guggenheim 5th Annual Inflammation &
Immunology Conference. Fireside chat on Tuesday, November
7, 2023 at 10:30 a.m. ET in New York, NY.
- Truist
Securities BioPharma Symposium. Management will
participate in investor meetings on Wednesday, November 8, 2023 in
New York, NY.
-
Jefferies London Healthcare Conference. Management
will participate in investor meetings on Tuesday, November 14, 2023
in London, UK.
A live webcast of the Guggenheim fireside chat may be accessed
on the Investor section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately 30 days following the fireside
chat.
About argenx
argenx is a global immunology company committed to improving the
lives of people suffering from severe autoimmune diseases.
Partnering with leading academic researchers through its Immunology
Innovation Program (IIP), argenx aims to translate immunology
breakthroughs into a world-class portfolio of novel antibody-based
medicines. argenx developed and is commercializing the first
approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan,
Israel, the EU, the UK, China and Canada. The Company is evaluating
efgartigimod in multiple serious autoimmune diseases and advancing
several earlier stage experimental medicines within its therapeutic
franchises. For more information, visit www.argenx.com and follow
us on LinkedIn, Twitter, and Instagram.
For further information, please contact:
Media:
Erin Murphyemurphy@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
Argen X (EU:ARGX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Argen X (EU:ARGX)
Historical Stock Chart
From Nov 2023 to Nov 2024
